Connect your AI

Agios Pharmaceuticals AGIO Price / sales

Price / sales at other companies

Bristol-Myers SquibbBMY

2.6×-0.1×

PfizerPFE

2.5×+0.2×

Vertex PharmaceuticalsVRTX

9.3×-1.9×

IncyteINCY

3.5×+0.8×

BioMarin PharmaceuticalsBMRN

3.4×-1.2×

PrecigenPGEN

102.3×—

Other financials

Income statement

Revenue$20.7M+138%

Gross profit$19.4M+154%

Operating income-$110.0M-3.2%

Net income-$99.1M-11.0%

EPS (diluted)-$1.69-9.0%

Balance sheet

Cash & equivalents$113.6M+43.9%

Total debt$35.7M-32.5%

Total equity$1.1B-24.4%

Total assets$1.2B-23.8%

Cash flow

Operating cash flow-$118.9M-6.7%

CapEx$769.0K+0.4%

Free cash flow-$119.7M-6.6%

Valuation

Market cap$2.12B+18.1%

Enterprise value$2.04B+15.2%

Profitability

Gross margin90%+2.5pp

Operating margin-720%-204pp

Net margin-639.8%—

FCF margin-582.5%-185pp

Returns & leverage

Return on equity-32.8%—

Debt / equity0×0.0×

Current ratio14.2×-4.3×

Where this comes from

Calculated from Agios Pharmaceuticals’s reported figures.

market cap/total revenue=30×

Based on the most recent quarter.

The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agios Pharmaceuticals's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Agios Pharmaceuticals's price / sales?: Agios Pharmaceuticals (AGIO) reported price / sales of 30× in Q1 2026.
How has Agios Pharmaceuticals's price / sales changed year-over-year?: Agios Pharmaceuticals's price / sales decreased by 33.8% year-over-year, from 45.3× to 30×.
What is the long-term trend for Agios Pharmaceuticals's price / sales?: Over 4 years (2020 to 2025), Agios Pharmaceuticals's price / sales has grown at a 26.2% compound annual growth rate (CAGR), from 11.6× to 29.4×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.